Overview
T cells are a component of the immune system that the body uses to combat cancer and other illnesses. Genetically altered T cells are known as chimeric antigen receptor T (CAR T) cells. Using the ability of altered T cells to locate and eradicate cancer cells, CAR T cell therapy improves the body's natural barriers against the illness.
Procedures
CAR-T Cell Therapy is carried out in several carefully coordinated stages:
Indications
CAR-T Cell Therapy may be recommended for patients with certain relapsed or treatment-resistant blood cancers, including:
- Acute Lymphoblastic Leukemia (ALL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Certain B-cell Non-Hodgkin Lymphomas
- Multiple Myeloma
- Other eligible hematological malignancies after specialist evaluation
Advantages
CAR-T Cell Therapy offers a personalized, targeted approach to treating certain blood cancers with the potential for improved outcomes.
Personalized Treatment
Harnesses the body's immune system to provide a highly personalized and innovative approach to cancer treatment.
Highly Targeted Therapy
Harnesses the body's immune system to provide a highly personalized and innovative approach to cancer treatment.
Effective for Relapsed Cancers
Harnesses the body's immune system to provide a highly personalized and innovative approach to cancer treatment.
Potential for Durable Remission
Harnesses the body's immune system to provide a highly personalized and innovative approach to cancer treatment.
Single Cell Infusion
Harnesses the body's immune system to provide a highly personalized and innovative approach to cancer treatment.
Advanced Precision Immunotherapy
Harnesses the body's immune system to provide a highly personalized and innovative approach to cancer treatment.
Book an Appointment